Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Fat tissue produces a variety of secreted proteins (adipocytokines) with important roles in metabolism. We isolated a newly identified adipocytokine, visfatin, that is highly enriched in the visceral fat of both humans and mice and whose expression level in plasma increases during the development of obesity. Visfatin corresponds to a protein identified previously as pre–B cell colony-enhancing factor (PBEF), a 52-kilodalton cytokine expressed in lymphocytes. Visfatin exerted insulin-mimetic effects in cultured cells and lowered plasma glucose levels in mice. Mice heterozygous for a targeted mutation in the visfatin gene had modestly higher levels of plasma glucose relative to wild-type littermates. Surprisingly, visfatin binds to and activates the insulin receptor. Further study of visfatin's physiological role may lead to new insights into glucose homeostasis and/or new therapies for metabolic disorders such as diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Local hypoxia could also play an important role in the attraction and retention of macrophages within the adipose tissue (82) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [82]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,238
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,088
Self-citationMaeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,083
Self-citationFujioka, S., Matsuzawa, Y., Tokunaga, K., & Tarui, S. (1987) · Metabolism · doi:10.1016/0026-0495(87)90063-1 · Cited by 1,207
Self-citationLeptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038
Self-citationCloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.
Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1431 · Cited by 1,019
Research works printed but not linked: 1
- B. Samal et al., Mol. Cell. Biol.14, 1431 (1994).
Cited by
Items 401–500 of 1,001
Measurement of salivary resistin, visfatin and adiponectin levels
Mamali, I., Roupas, N. D., Armeni, A. K., Theodoropoulou, A., Markou, K. B., & Georgopoulos, N. A. (2011) · Peptides · doi:10.1016/j.peptides.2011.11.007 · Cited by 81
Chen, C., Li, T., Li, C.-I., Liu, C.-S., Lin, W., Wu, M., Lai, M.-M., & Lin, C. (2007) · Metabolism · doi:10.1016/j.metabol.2007.04.018 · Cited by 82
Perinatal Circulating Visfatin Levels in Intrauterine Growth Restriction
Malamitsi‐Puchner, A., Briana, D. D., Boutsikou, M., Kouskouni, E. E., Hassiakos, D., & Gourgiotis, D. (2007) · PEDIATRICS · doi:10.1542/peds.2006-2589 · Cited by 78
Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population
Reinehr, T., & Roth, C. L. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1110-5 · Cited by 83
Lemor, A., Hosseini, A., Sauerwein, H., & Mielenz, M. (2009) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2009.01.004 · Cited by 92
Influence of thyroid dysfunction on serum concentrations of adipocytokines
Iglesias, P., & Díez, J. J. (2007) · Cytokine · doi:10.1016/j.cyto.2007.10.001 · Cited by 83
Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo
Formentini, L., Moroni, F., & Chiarugi, A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.02.017 · Cited by 85
Review: NAD + : A modulator of immune functions
Grahnert, A., Grahnert, A., Klein, C., Schilling, E., Wehrhahn, J., & Hauschildt, S. (2011) · Innate Immunity · doi:10.1177/1753425910361989 · Cited by 76
Quantification of Hepatic Steatosis with 3-T MR Imaging: Validation in ob/ob Mice
Hines, C. D. G., Yu, H., Shimakawa, A., McKenzie, C. A., Warner, T. F., Brittain, J. H., & Reeder, S. B. (2010) · Radiology · doi:10.1148/radiol.09090131 · Cited by 76
Bailey, S. D., Loredo-Osti, J. C., Lepage, P., Faith, J., Fontaine, J., Desbiens, K. M., Hudson, T. J., Bouchard, C., Gaudet, D., Pérusse, L., et al. (2006) · Diabetes · doi:10.2337/db06-0189 · Cited by 76
Sonoli, S. S., Shivprasad, S., Prasad, C. V. B., Patil, A. B., Desai, P., & Somannavar, M. S. (2011) · PubMed · Cited by 76
Beyond Fat Mass: Exploring the Role of Adipokines in Rheumatic Diseases
Scotece, M., Conde, J., Gómez, R., López, V., Lago, F., Gómez-Reino, J. J., & Gualillo, O. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/290142 · Cited by 77
AlZaim, I., Hammoud, S. H., Al-Koussa, H., Ghazi, A., Eid, A. H., & El-Yazbi, A. F. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.602088 · Cited by 73
“Visfatin elicits insulomimetic effects in adipocytes and an increased blood glucose level prompts an increase of serum visfatin (115, 118).”
BackgroundTherapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes
Imai, S.-I. (2009) · Frontiers in Bioscience · doi:10.2741/3428 · Cited by 75
Visfatin and its role in obesity development
Stastny, J., Vašků, J. B., & Vašků, A. (2012) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.08.011 · Cited by 89
A Visfatin Promoter Polymorphism Is Associated with Low‐Grade Inflammation and Type 2 Diabetes
Zhang, Y., Gottardo, L., Thompson, R., Powers, C. M., Nolan, D. A., Duffy, J. E., Marescotti, M. C., Avogaro, A., & Doria, A. (2006) · Obesity · doi:10.1038/oby.2006.247 · Cited by 81
Relationship Between Cerebrospinal Fluid Visfatin (PBEF/Nampt) Levels and Adiposity in Humans
Hallschmid, M., Randeva, H., Tan, B. K., Kern, W., & Lehnert, H. (2009) · Diabetes · doi:10.2337/db08-1176 · Cited by 75
Metabolically healthy obese individuals: Key protective factors
Gonçalves, C. G., Glade, M. J., & Meguid, M. M. (2015) · Nutrition · doi:10.1016/j.nut.2015.07.010 · Cited by 91
The role of visfatin in the pathogenesis of gestational diabetes mellitus
Gök, D. E., Yazıcı, M., Üçkaya, G., Bolu, Ş. E., Başaran, Y., Ozgurtas, T., Kiliç, S., & Kutlu, M. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346687 · Cited by 75
Adipokines influence the inflammatory balance in autoimmunity
Hutcheson, J. (2015) · Cytokine · doi:10.1016/j.cyto.2015.04.004 · Cited by 81
Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells
Anfossi, G., Russo, I., Doronzo, G., Pomero, A., & Trovati, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/174341 · Cited by 73
Nüsken, K., Dötsch, J., Rauh, M., Rascher, W., & Schneider, H. (2007) · Endocrinology · doi:10.1210/en.2007-0891 · Cited by 75
Wang, Y., Gao, C., Zhang, Y., Gao, J., Teng, F., Tian, W., Yang, W., Yan, Y., & Xue, F. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.109 · Cited by 74
Dupré, S. M., Burt, D. W., Talbot, R., Downing, A., Mouzaki, D., Waddington, D., Malpaux, B., Davis, J. R., Lincoln, G. A., & Loudon, A. S. I. (2008) · Endocrinology · doi:10.1210/en.2008-0834 · Cited by 86
Secretory function of adipose tissue
Kuryszko, J. J., Sławuta, P., & Sapikowski, G. (2016) · Polish Journal of Veterinary Sciences · doi:10.1515/pjvs-2016-0056 · Cited by 88
Dalamaga, Μ. (2013) · World Journal of Experimental Medicine · doi:10.5493/wjem.v3.i3.34 · Cited by 85
Elevated Visfatin/Pre-B-cell Colony-enhancing Factor Plasma Concentration in Ischemic Stroke
Lu, L.-F., Yang, S.-S., Wang, C.-P., Hung, W., Yu, T., Chiu, C., Chung, F., Shin, S., & Lee, Y. (2009) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2009.01.003 · Cited by 73
Decorin is a secreted protein associated with obesity and type 2 diabetes
Bolton, K. A., Segal, D., McMillan, J. S., Jowett, J. B. M., Heilbronn, L. K., Abberton, K. M., Zimmet, P., Chisholm, D. J., Collier, G. R., & Walder, K. R. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.41 · Cited by 76
Jacques, C., Holzenberger, M., Mladenovic, Z., Salvat, C., Pecchi, É., Berenbaum, F., & Gosset, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350215 · Cited by 72
Hormones of adipose tissue and their biologic role in lung cancer
Ntikoudi, E., Kiagia, M., Boura, P., & Syrigos, K. N. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.06.005 · Cited by 77
“Visfatin is another adipose tissue derived hormone initially suggested to act as an insulin-mimetic hormone, capable of binding directly to insulin receptor (IR) [101,102].”
BackgroundA Rare Variant in the Visfatin Gene (NAMPT/PBEF1) Is Associated With Protection From Obesity
Blakemore, A. I. F., Meyre, D., Delplanque, J., Vatin, V., Lecoeur, C., Marre, M., Tichet, J., Balkau, B., Froguel, P., & Walley, A. J. (2009) · Obesity · doi:10.1038/oby.2009.75 · Cited by 72
Biochemical Markers of Aging for Longitudinal Studies in Humans
Engelfriet, P. M., Jansen, E. H. J. M., Picavet, H. S. J., & Dolle, M. E. T. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs011 · Cited by 72
Mastorakos, G., Valsamakis, G., Papatheodorou, D., Barlas, I., Margeli, A., Boutsiadis, A., Kouskouni, E., Vitoratos, N., Papadimitriou, A., Papassotiriou, I., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.084731 · Cited by 76
Increase in visfatin after weight loss induced by gastroplastic surgery
Krzyzanowska, K., Mittermayer, F., Krugluger, W., Kopp, H. P., & Schernthaner, G. (2006) · Obesity · doi:10.1038/oby.2006.219 · Cited by 71
Liang, W. H., & Ye, D. D. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.06.002 · Cited by 82
Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis
Bae, Y.-H., Bae, M., Kim, S.-R., Lee, J. H., Wee, H., & Bae, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.042 · Cited by 71
Curcumin: A Naturally Occurring Modulator of Adipokines in Diabetes
Hajavi, J., Momtazi‐Borojeni, A. A., Johnston, T. P., Banach, M., Majeed, M. A., & Sahebkar, A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26121 · Cited by 74
“To sum up, the impact of visfatin on insulin signaling is attributed to induction of tyrosine phosphorylation of the insulin receptors, IRS-1 and 2, and activation of phosphatidylinositol-3-kinase, PKB, and MAPK [Fukuhara et al., 2005].”
BackgroundAdipokines and the cardiovascular system: mechanisms mediating health and disease
Northcott, J. M., Yeganeh, A., Taylor, C. G., Zahradka, P. C., & Wigle, J. T. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-053 · Cited by 81
Adipokines in inflammation, insulin resistance and cardiovascular disease
Li, Z., Wang, P., & Miao, C. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05602.x · Cited by 77
Obesity and polymorphisms in genes regulating human adipose tissue
Dahlman, I. A., & Arner, P. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803657 · Cited by 83
Plasma Visfatin Concentration as a Surrogate Marker for Visceral Fat Accumulation in Obese Children
Araki, S., Dobashi, K., Kubo, K., Kawagoe, R., Yamamoto, Y., Kawada, Y., Asayama, K., & Shirahata, A. (2008) · Obesity · doi:10.1038/oby.2007.54 · Cited by 79
Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis
Franco-Trepat, E., Guillán-Fresco, M., Alonso-Pérez, A., Jorge-Mora, A., Francisco, V., Gualillo, O., & Gómez, R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081178 · Cited by 70
“Although visfatin has been controversially related with insulin receptor [12,94], the specific receptor for visfatin has yet to be described.”
BackgroundThe role of adipocytokines in fetal growth
Briana, D. D., & Malamitsi‐Puchner, A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05650.x · Cited by 71
Serum Fetuin-A Concentration and Endothelial Dysfunction in Chronic Kidney Disease
Çağlar, K., Yılmaz, M. İ., Sağlam, M., Çakır, E., Kılıç, S., Sönmez, A., Eyileten, T., Yenicesu, M., Oğuz, Y., Taşar, M., et al. (2008) · Nephron Clinical Practice · doi:10.1159/000120209 · Cited by 69
“This conflicts with a previous study showing associations between visfatin and glucose levels in mice andinvitro [ 10 ].”
BackgroundResultWang (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.621 · Cited by 69
Metabolic and molecular insights into an essential role of nicotinamide phosphoribosyltransferase
Zhang, L. Q., Van Haandel, L., Xiong, M., Huang, P., Heruth, D. P., Bi, C., Gaedigk, R., Jiang, X., Li, D.-Y., Wyckoff, G., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.132 · Cited by 69
Neuroendocrine and metabolic effects of adipocyte-derived hormones
Jackson, M. B., & Ahima, R. S. (2006) · Clinical Science · doi:10.1042/cs20050243 · Cited by 68
Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
Navas, L. E., & Carnero, A. (2022) · Cells · doi:10.3390/cells11172627 · Cited by 68
The inflammatory profile and liver damage of a sucrose-rich diet in mice
Oliveira, L. S. C., Santos, D. A., Barbosa‐da‐Silva, S., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.10.006 · Cited by 73
“These substances include leptin, adiponectin, resistin, TNF-alpha and others [30–32].”
BackgroundCellular inflammatory responses: Novel insights for obesity and insulin resistance
Chen, H. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.03.003 · Cited by 81
Hackl, H., Burkard, T. R., Sturn, A., Rubio, R., Schleiffer, A., Tian, S., Quackenbush, J., Eisenhaber, F., & Trajanoski, Z. (2005) · Genome Biology · doi:10.1186/gb-2005-6-13-r108 · Cited by 68
Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome
Ozkaya, M., Cakal, E., Ustun, Y., & Engin-Ustun, Y. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.058 · Cited by 67
Adiponectin: A multitasking player in the field of liver diseases
Silva, T. E., Colombo, G., & Schiavon, L. D. L. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.11.004 · Cited by 74
Decreased Visfatin after Exercise Training Correlates with Improved Glucose Tolerance
HAUS, J. M., SOLOMON, T. P. J., MARCHETTI, C. M., O'LEARY, V. B., BROOKS, L. M., GONZALEZ, F., & KIRWAN, J. P. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318195bad5 · Cited by 67
Matsumoto, S., Takebayashi, K., & Aso, Y. (2006) · Metabolism · doi:10.1016/j.metabol.2006.07.025 · Cited by 68
“adipocytokine that mimics the action of insulin [9]) in type 2”
BackgroundInfluentialInfluence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
Aller, R., de Luis, D. A., Izaola, O., Sagrado, M. G., Conde, R., Velasco, M. C., Alvarez, T., Pacheco, D., & González, J. M. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0539-9 · Cited by 79
Lin, Y., Chen, Y., & Chen, S.-A. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.01.004 · Cited by 72
Catalán, V., Gómez‐Ambrosi, J., Rodríguez, A., Ramírez, B., Silva, C., Rotellar, F., Cienfuegos, J. A., Salvador, J., & Frühbeck, G. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.09.008 · Cited by 78
“NAMPT, also named visfatin, has been also identified as a visceral fatderived adipokine with insulin-mimetic effects by binding to and activating the insulin receptor [13].”
BackgroundResultAdipose expression of adipocytokines in women with polycystic ovary syndrome
Svendsen, P. F., Christiansen, M., Hedley, P. L., Nilas, L., Pedersen, S. B., & Madsbad, S. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.056 · Cited by 74
Serum visfatin levels in late pregnancy and pre‐eclampsia
Hu, W., Wang, Z., Wang, H., Huang, H., & Dong, M. (2008) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340801976012 · Cited by 74
The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile
Wang, P., van Greevenbroek, M. M. J., Bouwman, F. G., Brouwers, M. C. G. J., Kallen, C., Smit, E., Keijer, J., & Mariman, E. C. M. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0262-y · Cited by 68
Adipokines as drug targets in joint and bone disease
Scotece, M., Conde, J., Vuolteenaho, K., Koskinen, A., López, V., Gómez-Reino, J. J., Lago, F., Moilanen, E., & Gualillo, O. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.012 · Cited by 79
The role of obesity and adipose tissue dysfunction in gestational diabetes mellitus
Šimják, P., Cinkajzlová, A., Anderlová, K., Pařízek, A., Mráz, M., Kršek, M., & Haluzík, M. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0032 · Cited by 81
“Another adipokine, visfatin, was originally considered potentially protective against insulin resistance but its ability to directly bind to the insulin receptor and activate insulin signaling pathway was not confirmed (the original article was hereafter retracted by the authors (Fukuhara et al. 2005)).”
BackgroundImmunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis
Chen, S., Lin, G., Chen, J.-W., Wang, K., Tien, C., Hu, C.-F., Chang, C.-N., Hsu, W.-F., Fan, H., & Sytwu, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061332 · Cited by 77
“Visfatin is a newly discovered adipocyte enzyme [131] that promotes the production of IL-6 and TNF-α via the inhibition of miR-199a-5p expression through the ERK, p38, and JNK pathways and is also a potential target for disease biomarker and drug development in inflammatory arthritis [132].”
BackgroundSex Differences in Adiposity and Cardiovascular Diseases
Li, H., Konja, D., Wang, L., & Wang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169338 · Cited by 80
Cannabinoid Type 1 Receptor: Another Arrow in the Adipocytes’ Bow
Bellocchio, L., Cervino, C., Vicennati, V., Pasquali, R., & Pagotto, U. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01682.x · Cited by 68
Böttcher, Y., Teupser, D., Enigk, B., Berndt, J., Klöting, N., Schön, M. R., Thiery, J., Blüher, M., Stümvoll, M., & Kovacs, P. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0149 · Cited by 67
Insulin Suppresses Endotoxin-Induced Oxidative, Nitrosative, and Inflammatory Stress in Humans
Dandona, P., Ghanim, H., Bandyopadhyay, A., Korzeniewski, K., Sia, C. L., Dhindsa, S., & Chaudhuri, A. (2010) · Diabetes Care · doi:10.2337/dc10-0929 · Cited by 68
The role of visfatin in pathogenesis of gestational diabetes (GDM)
Radzicka, S., Pietryga, M., Iciek, R., & Brązert, J. (2018) · Ginekologia Polska · doi:10.5603/gp.a2018.0088 · Cited by 72
Gu, X., Wang, L., Liu, S., & Shan, T. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155379 · Cited by 79
Nourbakhsh, M., Nourbakhsh, M., Gholinejad, Z., & Razzaghy‐Azar, M. (2015) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.1003594 · Cited by 67
Zhang, C., Tong, J., & Huang, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069963 · Cited by 65
Boini, K. M., Zhang, C., Xia, M., Han, W., Brimson, C. A., Poklis, J. L., & Li, P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.09.001 · Cited by 68
Vallejo, S., Romacho, T., Angulo, J., Villalobos, L. A., Cercas, E., Leivas, A., Bermejo, E., Carraro, R., Sánchez‐Ferrer, C. F., & Peiró, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027299 · Cited by 65
Diet, obesity and diabetes: a current update
Walker, C. G., Zariwala, M. G., Holness, M. J., & SUGDEN, M. C. (2007) · Clinical Science · doi:10.1042/cs20060150 · Cited by 66
Emerging role of adipokines as mediators in atherosclerosis
Zhang, H., Cui, J., & Zhang, C. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i11.370 · Cited by 75
Kawashima, K., Maeda, K., Saigo, C., Kito, Y., Yoshida, K., & Takeuchi, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040866 · Cited by 68
Adipokines in rheumatoid arthritis
Fatel, E. C. D. S., Rosa, F. T., Simão, A. N. C., & Dichi, I. (2018) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-018-0026-8 · Cited by 67
“It is primarily found in liver, bone marrow and muscle tissue, but also produced by adipose tissue and secreted by macrophage [43].”
BackgroundAudrito, V., Managò, A., Gaudino, F., Sorci, L., Messana, V. G., Raffaelli, N., & Deaglio, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01720 · Cited by 64
“In 2005, Fukuhara (108) identified eNAMPT Frontiers in Immunology | www.frontiersin.org 5 July 2019 | Volume 10 | Article 1720 FIGURE 2 | NAD metabolism overview.”
Sayers, S. R., Beavil, R. L., Fine, N. H. F., Huang, G. C., Choudhary, P., Pacholarz, K. J., Barran, P. E., Butterworth, S., Mills, C. E., Cruickshank, J. K., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05029-y · Cited by 66
Goralski, K. B., & Sinal, C. J. (2007) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-092 · Cited by 82
Adipokines in the treatment of diabetes mellitus and obesity
Catalán, V., Gómez‐Ambrosi, J., Rodríguez, A., Salvador, J., & Frühbeck, G. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802618811 · Cited by 72
Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation
Plati, E., Kouskouni, E. E., Malamitsi‐Puchner, A., Boutsikou, M., Kaparos, G., & Baka, S. G. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.055 · Cited by 69
Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells
Romacho, T., Villalobos, L. A., Cercas, E., Carraro, R., Sánchez‐Ferrer, C. F., & Peiró, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078283 · Cited by 71
Xia, M., Zhang, C., Boini, K. M., Thacker, A. M., & Li, P.-L. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq286 · Cited by 63
Identification and treatment of metabolic complications in pediatric obesity
Ode, K. L., Frohnert, B. I., & Nathan, B. M. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-009-9115-7 · Cited by 72
Peripheral signalling involved in energy homeostasis control
Lancha, A., Frühbeck, G., & Gómez‐Ambrosi, J. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000145 · Cited by 74
Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities
Chen, H., Wang, S., Zhang, H., Nice, E. C., & Huang, C. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2016.1190649 · Cited by 66
Interplay of adipokines and myokines in cancer pathophysiology: Emerging therapeutic implications
Dalamaga, M. (2013) · World Journal of Experimental Medicine · doi:10.5493/wjem.v3.i3.26 · Cited by 64
Erfani, S., Khaksari, M., Oryan, S., Shamsaei, N., Aboutaleb, N., & Nikbakht, F. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0486-1 · Cited by 65
Scotece, M., Conde, J., Gómez, R., López, V., Pino, J., González, A., Lago, F., Gómez-Reino, J. J., & Gualillo, O. (2012) · Mediators of Inflammation · doi:10.1155/2012/125458 · Cited by 63
Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS
Zheng, S.-H., & Li, X.-L. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1111327 · Cited by 63
Pérez-Echarri, N., Pérez‐Matute, P., Marcos‐Gómeź, B., Martínez, J. A., & Moreno-Aliaga, M. J. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508048307 · Cited by 64
Chen, W., Bao, J., Feng, J., Hu, P., Shi, Z., & Wu, L. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.230 · Cited by 63
Sun, Q., Li, L., Li, R., Yang, M., Liu, H., Nowicki, M. J., Zong, H., Xu, J., & Yang, G. (2009) · Annals of Medicine · doi:10.1080/07853890902729760 · Cited by 72
Çınar, N., & Gürlek, A. (2013) · Endocrine Connections · doi:10.1530/ec-13-0061 · Cited by 70
Angiotensin inhibition stimulates PPARγ and the release of visfatin
Storka, A., Vojtassakova, E., Mueller, M., Kapiotis, S., Haider, D. G., Jungbauer, A., & Wolzt, M. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02025.x · Cited by 62
Choi, K.-H., Joo, B., Sun, S.-T., Park, M.-J., Son, J.-B., Joo, J.-K., & Lee, K. S. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.02.032 · Cited by 67
Zhao, Y., Liu, X., Tian, W., Guan, Y., Wang, P., & Miao, C. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12273 · Cited by 61
Adipose tissue as source and target for novel therapies
Klein, J. C., Perwitz, N., Kraus, D., & Faßhauer, M. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.11.008 · Cited by 70
Metadata
- Authors
- Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., Watanabe, E., Takagi, T., Akiyoshi, M., Ohtsubo, T., Kihara, S., Yamashita, S., Makishima, M., Funahashi, T., Yamanaka, S., Hiramatsu, R., Matsuzawa, Y., & Shimomura, I.
- Affiliations
- Japan Society for the Promotion of Science (JP)
- Department of Medicine and Pathophysiology, Graduate School of Medicine, and Department of Organismal Biosystems, Graduate School of Frontier Biosciences, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Corresponding author
- Fukuhara, Atsunori
- Matsuda, Morihiro
- Nishizawa, Masako
- Shimomura, Iichiro
- ORCID
- Venue
- Science
- Published
- 2005-01-21
- Volume
- 307
- Issue
- 5708
- Pages
- 426-430
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2135110328
- Cited by
- 1,906
- References
- 17
- Citations by year
- 2026: 10 · 2025: 24 · 2024: 45 · 2023: 55 · 2022: 62 · 2021: 53 · 2020: 52 · 2019: 76 · 2018: 93 · 2017: 71 · 2016: 82 · 2015: 122 · 2014: 117 · 2013: 128 · 2012: 107
- FWCI
- 74.12
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2007-10-26)
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- visfatin, PBEF, visceral fat, adipokines, insulin-like activity, insulin receptor, glucose homeostasis, obesity, diabetes mellitus, plasma glucose, knockout mice
- MeSH terms
- Adipose Tissue, Animals, Binding Sites, Blood Glucose, Cell Line, Cells, Cultured, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Female, Gene Expression Regulation, Humans, Insulin, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Obese, Phosphorylation, Receptor, Insulin, Recombinant Proteins, Viscera, Signal Transduction, Cytokines, Adipocytes, Gene Targeting, Molecular Mimicry, Gene Expression Profiling, Muscle Cells, Subcutaneous Tissue, Mice, Nicotinamide Phosphoribosyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.